S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN-LABEL STUDY. (23rd June 2022) - Michot, J.-M.; Chavez, J. C.; Carpio, C; Ferrari, S.; Feldman, T. A.; Morillo, D.; Kuruvilla, J.; Pinto, A.; Ribrag, V.; Bachy, E; Buchholz, T. J.; Carrancio, S.; et al.